Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cynvec, a privately-held biopharmaceutical company, has appointed Frank Stonebanks as its new president and CEO to lead the company's next phase of growth. In addition to his role as CEO, Mr Stonebanks will serve on Cynvec's board of directors.
Subscribe to our email newsletter
Prior to joining Cynvec, Mr Stonebanks led the global healthcare and life science mergers and acquisitions efforts at IBM, advising the company on its healthcare and life science strategy.
Mr Stonebanks has completed his undergraduate degree in Exercise Physiology at the University of Victoria, British Columbia, Canada and his MBA in pharmaceutical marketing at St Joseph’s University in Philadelphia.
Steve Blumenthal, chairman of the board at Cynvec, said: “Frank brings a remarkably consistent track record of accomplishment in building start-ups into successful companies. He is a proven leader who will serve as the foundation of our management team to advance our promising preclinical compounds into the clinic.”